How a Smart Molecular Switch Could Revolutionize Cancer Immunotherapy Cutting-edge research from MIT and Stanford has opened a promising path in immunotherapy, offering hope for patients with cancers that have so far resisted treatment. The secret lies in a novel way to... antibody therapy biotechnology cancer research clinical trials glycans immune checkpoints immunotherapy